Vistra Corp. (NYSE:VST) experienced a modest decline in early trading on Friday, with shares slipping 1.8% to $138.79 shortly after the market opened. The pullback came even as the company reported a robust 31% increase in adjusted EBITDA for the second quarter, reaching $1.767 billion. However, net income fell 6.7% to $305 million, and management maintained its full-year 2026 outlook, which appears to have tempered investor enthusiasm.
The unchanged guidance implies a significant acceleration in the second half of the year. Vistra reported $3.261 billion in adjusted EBITDA for the first six months, representing 45.3% of the midpoint of its $7.2 billion full-year guidance range of $6.8 billion to $7.6 billion. To hit the midpoint, the company needs to generate $3.939 billion in the second half, a 20.8% increase over the first half. The required range spans from $3.539 billion to $4.339 billion, based on company-provided figures.
Investors are keenly focused on the company's ability to deliver this back-half surge. Vistra's hedging strategy provides some reassurance: it has secured hedges for approximately 100% of its projected 2026 generation, with about 94% for 2027 and 72% for 2028. This reduces immediate commodity price risk, placing greater emphasis on plant reliability, capacity payments, and operational execution.
The quarterly breakdown highlights the sources of growth. Operating revenue came in at $4.017 billion, down 5.5% from $4.250 billion a year earlier. Net income declined 6.7% to $305 million. Adjusted EBITDA rose 31% to $1.767 billion, driven by strong performance in the Texas and East segments, which posted gains of 119% and 53.6%, respectively. Retail adjusted EBITDA grew 2.2% to $773 million.
Generation was the standout, with first-half EBITDA of $2.420 billion, up 46.8% year over year. This segment now accounts for 74.2% of total EBITDA, up from 63.7% in the prior year. Retail EBITDA, however, slipped 10.5% to $841 million. Chief Executive Jim Burke described the results as "another strong quarter," noting that commercial availability exceeded 97% during extreme heat conditions in both Texas and PJM.
Looking ahead, Vistra's maintained outlook signals strong cash generation potential. The company's 2026 adjusted free cash flow before growth guidance is set at $3.925 billion to $4.725 billion, which supports capital distributions and investments. Management also reiterated a medium-term cash conversion target of over 60%. For 2027, the company presents a midpoint opportunity of $7.4 billion to $7.8 billion, though this is indicative rather than official guidance.
Growth investments remain robust. Vistra is allocating up to $1 billion toward Helix Digital Infrastructure and has received federal clearance for its acquisition of Cogentrix. The 2027 outlook does not incorporate potential upsides from Cogentrix or agreements with Meta Platforms (NASDAQ:META).
Recent share repurchases provide insight into valuation. Vistra bought approximately 437,000 shares at an average price of $154.78 from June 30 to August 3. Friday's delayed quote traded about 10% lower than that level. The company still has roughly $1.2 billion remaining under its buyback authorization.
Peer performance varied, with Constellation Energy (NASDAQ:CEG) up 1.43%, NRG Energy (NYSE:NRG) gaining 1.08%, and Talen Energy (NASDAQ:TLN) rising 0.69%. This divergence suggests Vistra's decline is company-specific rather than a sector-wide move, with investors focusing on the flat guidance rather than the quarterly beat.
Wall Street remains optimistic. Based on 21 active FactSet recommendations, the consensus is Buy, with 17 Buy ratings and 2 Overweight. The average price target stands at $228, roughly 64% above Friday's late price, with a median target of $222 and a range of $181 to $313. However, projected 2026 earnings per share have been revised down to $9.06 from $9.25 a month ago.
Key risks include hedge valuation changes, which can cause significant GAAP volatility, and potential hits to cash generation from plant outages, severe weather, or rising interest expenses. Delays in finalizing the Cogentrix merger could also dampen the anticipated growth boost. The immediate test is clear: Vistra must convert its strong summer performance into the second-half earnings acceleration embedded in its guidance.
